As of Aug 22
| +0.35 / +3.54%|
The 5 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 11.00, with a high estimate of 20.00 and a low estimate of 6.00. The median estimate represents a +7.32% increase from the last price of 10.25.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.